Sylvain Latour

Title: Sylvain Latour: Innovator in CTP Detection and Quantification

Introduction: Sylvain Latour, an accomplished inventor based in Vitry sur Seine, France, has made significant contributions to the field of biochemistry through his innovative work. With one patented invention to his name, his research is primarily focused on methods for detecting and quantifying CTP and CTP synthase activity.

Latest Patents: Latour's patent, titled "Methods for detecting or quantifying CTP and CTP synthase activity," presents a pioneering method for identifying CTP in cell samples that contain multiple nucleotide triphosphates. This method utilizes cationic ion pairing chromatography coupled with mass spectrometry. Furthermore, his patent outlines a technique for assessing CTP synthase activity based on the detection of CTP. This innovation has promising applications in screening for potential immunosuppressive or anti-cancer compounds and in determining the appropriate dosages of these compounds for treating patients by inhibiting CTP synthase activity.

Career Highlights: Throughout his career, Sylvain Latour has worked with notable organizations such as Assistance Publique-Hôpitaux De Paris and Imagine Institut Des Maladies Genétiques Necker Enfants Malades. His endeavors in these institutions have allowed him to refine his research and make impactful contributions to medical science.

Collaborations: Latour has collaborated with esteemed colleagues, including Sylvia Sanquer and Anne-Claire Boschat. These partnerships have enhanced his research capabilities and fostered an environment conducive to innovation in the field of genetics and biochemistry.

Conclusion: Sylvain Latour's work illustrates an essential intersection of innovation and healthcare, particularly in the realm of immunosuppressive and anti-cancer therapeutics. His patented methods stand as a testament to his expertise and commitment to improving medical research and patient outcomes through inventive solutions.